MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: Alfred E. Mann
Vivani Medical Inc., (NASDAQ: VANI)*, formerly, Second Sight (NASDAQ: EYES) - (WH Mtg)
Organization & Developments: Second Sight
Parents
Vivani Medical Inc., (NASDAQ: VANI)*, formerly, Second Sight (NASDAQ: EYES) - (WH Mtg)
Children
*People with retinal-degeneration diseases, such as retinitis pigmentosa and macular degeneration, lose their sight as the cells
*Retinal implants can take over for these lost cells, converting light into neural signals that are then interpreted by the brain
*Simpler versions of these devices, developed by researchers at USC and other institutions, have already been tested in humans, g
*Such as the ability to detect light and to occasionally distinguish between simple objects
*The device, developed by Mark Humayun and colleagues at USC, consists of a tiny chip dotted with hair-thin electrodes
2011: A Bionic Eye Comes to Market (2011)
2011: Argus II Retinal Prosthesis Gets European Clearance (2011)
2013 Medical Device Manufacturer of the Year Finalists: Second Sight Medical Products
2013: All Eyes on Second Sight (2013)
2013: Bionic eye maker has vision of the future (2013)
2013: Second Sights First Bionic Eye for U S Market (2013)
2018: Second Sight Medical Products: Riding The Cash Roller Coaster To Nowhere - Second Sight Medical Products (NASDAQ:EYES)
2021: Second Sight Medical Products Looks Overvalued
2022: ‘Fantastic technology and a lousy company’: Second Sight’s ‘bionic eyes’ have gone obsolete while still implanted, report finds
2022: Bionic eye recipients left in the dark with obsolete tech
2022: Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
2024: EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
2024: EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows
2024: Vivani to start in-human trial for GLP-1 implant for treating obesity
Jumps
*Key People: Second Sight
Finance & Acquisitions: Second Sight